Oncology News and Research

RSS

Oncology, meaning bulk, mass, or tumor, and the suffix ''-logy'', meaning "study of") is a branch of medicine that deals with tumors (cancer). A medical professional who practices oncology is an ''oncologist''.

Novel anticancer agents show promise to control tumor growth in nearly every cancer type

A gene called MYC has become one of the hottest targets for cancer researchers around the world. MYC is known to drive tumor growth in nearly all cancer types - but successfully targeting the gene has proven to be a challenge.

9 Jul 2019

Many thyroid cancer patients have no choice about radioactive iodine, study reveals

After thyroid cancer surgery, many patients should be in the position of deciding with their doctors whether to pursue treatment with radioactive iodine to help ease long-term follow-up and offer reassurance that the cancer is gone.

9 Jul 2019

Study suggests usefulness of more flexible dose of regorafenib to relieve side-effects in mCRC patients

Medical oncologists administer anticancer drug regorafenib to try to improve overall survival in patients with metastatic colorectal cancer who have ceased to respond to standard therapy (known as refractory mCRC).

7 Jul 2019

Sports playbook can help generate more accurate prognoses for cancer patients

In this season of global soccer competitions and hotly contested political primaries, bookies and pundits are scouring every evolving scrap of information and sifting through mountains of data in an effort to predict the outcome of the next game or election.

4 Jul 2019

Role of hospital and health-system pharmacists in drug therapy monitoring

As hospitals look for ways to stem the opioid crisis, a survey of health-system pharmacy directors released today found that most large health systems have active stewardship programs to prevent the misuse of opioids -- with pharmacists playing a key role in detecting drug diversion and identifying strategies to encourage appropriate opioid prescribing.

4 Jul 2019

Researcher finds possible strategy for killing cancer cells in children

In Belgium, there are 70,000 new adult cases of cancer every year, compared to 350 in children. Owing to lack of interest from pharmaceutical groups, treatments for pediatric cancers are developing much less rapidly than those for adults.

4 Jul 2019

Non-pathogenic bacteria engineered as Trojan Horse to treat tumors from within

The emerging field of synthetic biology-designing new biological components and systems-is revolutionizing medicine.

4 Jul 2019

$FDA grants accelerated approval to new treatment for refractory multiple myeloma$

FDA grants accelerated approval to new treatment for refractory multiple myeloma

Today, the U.S. Food and Drug Administration granted accelerated approval to Xpovio (selinexor) tablets in combination with the corticosteroid dexamethasone for the treatment of adult patients with relapsed refractory multiple myeloma who have received at least four prior therapies and whose disease is resistant to several other forms of treatment, including at least two proteasome inhibitors, at least two immunomodulatory agents, and an anti-CD38 monoclonal antibody.

3 Jul 2019

New EU-funded research project aims to fight breast cancer

The ability to control key forces that drive biological functioning would be a boon for a number of medical fields. With a focus on breast cancer, an EU-funded project is bringing together different research communities to work towards understanding and controlling cellular mechanics.

3 Jul 2019

Long-term follow-up of childhood cancer survivors is essential to maintain bone health

Advances in the treatment of children and adolescents with cancer have led to substantial improvements in survival, with a 5-year survival rate of childhood cancer close to 80%.

3 Jul 2019

Study shows promise for a drug to extend life of patients with ovarian cancer

Women with ovarian cancer who have undergone four or more rounds of chemotherapy typically haven't had much hope that another treatment option will lengthen their lives in a meaningful way.

3 Jul 2019

Scientists aim to develop new ointment that could reduce risks of primary skin cancer

Scientists from Far Eastern Federal University, V.I. Vernadsky Crimean Federal University, Dmitry Mendeleev University of Chemical Technology, and Far Eastern Branch of the Russian Academy of Sciences, assumed the risks of primary skin cancer and its recurrences can be significantly reduced by applying the ointment with antisense oligonucleotides which are short DNA, RNA fragments used in oncology to suppress the synthesis of tumor proteins.

3 Jul 2019

Research reveals key cellular mechanism leading to aggressive prostate cancer

Prostate cancer represents a major health challenge and there is currently no effective treatment once it has advanced to the aggressive, metastatic stage.

3 Jul 2019

New resistance mechanism that prevent formation of blood vessels

Researchers at IDIBELL-ICO describe a new resistance mechanism to therapies that prevent the formation of blood vessels

3 Jul 2019

New telementoring program seeks to improve quality of care for breast cancer patients

A new program led by The University of Kansas Cancer Center seeks to improve community oncology providers' knowledge of genetic testing in breast cancer patients, as well as provide tools to allow genetic counseling and testing to be incorporated in their clinical practice.

2 Jul 2019

$Hypofractionated proton therapy for prostate cancer can be just as effective as standard treatment$

Hypofractionated proton therapy for prostate cancer can be just as effective as standard treatment

Treating prostate cancer with higher doses of proton therapy over a shorter amount of time leads to similar outcomes when compared to standard dose levels and treatments and is safe for patients, according to a new study examining the risk of long-term side-effects from the treatment.

2 Jul 2019

Gene mutation discovery leads to novel treatment for patient with severe lymphatic condition

Faced with a preteen boy in pain and struggling to breathe from a severe, deteriorating rare condition, researchers at Children's Hospital of Philadelphia identified the responsible gene mutation and harnessed that knowledge to develop a novel treatment that dramatically improved the problem.

2 Jul 2019

Oncology News and Research

Further Reading

Novel anticancer agents show promise to control tumor growth in nearly every cancer type

Many thyroid cancer patients have no choice about radioactive iodine, study reveals

Study suggests usefulness of more flexible dose of regorafenib to relieve side-effects in mCRC patients

Sports playbook can help generate more accurate prognoses for cancer patients

Role of hospital and health-system pharmacists in drug therapy monitoring

Researcher finds possible strategy for killing cancer cells in children

Non-pathogenic bacteria engineered as Trojan Horse to treat tumors from within

FDA grants accelerated approval to new treatment for refractory multiple myeloma

New EU-funded research project aims to fight breast cancer

Long-term follow-up of childhood cancer survivors is essential to maintain bone health

Study shows promise for a drug to extend life of patients with ovarian cancer

Scientists aim to develop new ointment that could reduce risks of primary skin cancer

Research reveals key cellular mechanism leading to aggressive prostate cancer

New resistance mechanism that prevent formation of blood vessels

New telementoring program seeks to improve quality of care for breast cancer patients

Hypofractionated proton therapy for prostate cancer can be just as effective as standard treatment

Gene mutation discovery leads to novel treatment for patient with severe lymphatic condition

Scientists uncover new pathway to make cancers self-destruct

Have cancer, must travel: Patients left in lurch after hospital closes

New diagnostic test could end unnecessary chemotherapy for breast cancer

Your guide to microplate readers for cancer research eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News